Sanjivani Parenteral has announced the financial results for the first quarter of FY27. The company reported a Total Income of ₹23.99 Cr, up 33.81% year-on-year.

EBITDA surged 61.04% to ₹4.32 Cr, with margins improving to 18.01%. Net Profit rose 43.94% to ₹2.49 Cr, and EPS stood at ₹2.03. Management highlighted robust operational performance, driven by export recovery and the gradual scale-up of its Pune IV Fluid facility.

The company remains focused on strengthening manufacturing, expanding its product portfolio, and enhancing market presence to drive sustainable growth.